pathos.com
AI-friendly mirror of pathos.com · Updated April 25, 2026
Total Pages
26
Total Words
19,374
Last Updated
April 25, 2026
Resources
- llms.txt— AI crawler index (llmstxt.org spec)
- sitemap.xml— XML sitemap for crawler discovery
- robots.txt— Crawler directives
- About This Cache— Methodology, technical details, and usage guidelines
Identity
- identity.mdpublic
- voice.mdpublic
- manifest.jsonpublic
Directory
Internal data
- Homepage
- news 5
- privacy-policy 1
- about-us 1
- Pathos AI Doses First Patient in Phase 1b/2a Clinical Trial of Pocenbrodib, a CBP/p300 Inhibitor
- home-old 1
- careers 1
- pathos-ai-completes-acquisition-of-rain-oncology 1
- Pathos Expands Pipeline With Worldwide License of Phase 2-ready Program, a Brain-penetrant, PRMT5 Inhibitor
- pipeline 1
- platform-old 1
- Pathos Signs Strategic Agreements with AstraZeneca and Tempus to Develop the Largest Multimodal Foundation Model in Oncology
- Pathos Launches Precision Oncology Pipeline With License of First Phase I Program, a CBP/p300 Inhibitor
- Pathos AI Closes $62M Oversubscribed Series C Round of Financing to Accelerate its Platform Approach to Drug Development
- Pathos AI Secures $365 Million in Series D Financing to Advance Oncology Drug Development Through AI
- Re-engineering Drug Development for Precision Medicine
- platform 1
- Pathos AI Appoints Iker Huerga as Chief Executive Officer to Lead the Next Era of AI-Enabled Drug Development
- patients 1
- contact-us 1
- partner_with_us 1
- partners 1